Trademark Overview
On Friday, March 1, 2024, a trademark application was filed for VSE with the United States Patent and Trademark Office. The USPTO has given the VSE trademark a serial number of 98429879. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, December 11, 2024. This trademark is owned by Virica Biotech Inc.. The VSE trademark is filed in the Chemical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Biological production, namely, custom manufacture of biological preparations in the field of gene therapy and cell therapies; biological production, namely, custom manufacture of biological preparations in the field of vaccines
Cell culture reagents for laboratory use, namely, for research use; cell culture reagents for scientific and research purposes; antibody reagents for scientific purposes; diagnostic reagents for medical-scientific research use; chemical preparations for the use in the production of medicines; chemical preparations for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; biochemical preparations for scientific purposes; catalysts in the nature of small molecules for use in increasing viral yield for use in the manufacture of vaccines and viral medicines; chemical and biochemical preparations for scientific use, research use, and laboratory research use; chemical and biochemical preparations for scientific use and for scientific research use; reagents for scientific and research use, in the field of genetics, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and production ...
scientific research and analysis for scientific research purposes in the field of gene and cell therapies; scientific research and analysis for scientific research purposes in the field of vaccines; research and development in the field of vaccines; testing services in the field of vaccines; laboratory research in the field of gene expression; research in the field of gene therapy; research and development in the medical biotechnology field; development of biotechnology; research and development in the pharmaceutical and biotechnology fields
